KEEPING YOU UP TO DATEClearstate Healthcare InsightsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Infectious Diseases Trend Monitor: India The Indian government is increasing its investment on… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Infectious Diseases Trend Monitor: China China’s government is building up the country’s in vitro… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Asia-Pacific infectious disease diagnostics market trends In Asia-Pacific (APAC), many countries continue to build up… In-vitro diagnostics | Infectious Diseases Testing Monitor | Uncategorised | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Infectious Diseases Trend Monitor: Australia Australia’s government continues to invest in… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Infectious Diseases Trend Monitor: Japan Infectious disease testing is highly accessible in Japan.… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Cancer biomarker testing to grow in Asia The cancer burden in Asia is increasing, with new cancer… Cancer diagnostics | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Size and Share Plus | The Gateway
Q2 2022 IVD China: point-of-care infectious-disease testing outperforms during the latest covid surge The impact of China’s latest covid-19 surge heads the… Centralised Diagnostics (CEDx) | Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | Covid-19 testing | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Tissue Diagnostics (TDx)
Competition in the APAC IVD infectious diseases diagnostics market Competition in Asia-Pacific’s infectious diseases… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | IVD Gateway
Keeping ahead of infectious diseases in Asia-Pacific with increased testing Our new briefing paper looks at the testing trends in… Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now